225 related articles for article (PubMed ID: 12430928)
1. Molecular pathogenesis of MDS.
Hirai H
Int J Hematol; 2002 Aug; 76 Suppl 2():213-21. PubMed ID: 12430928
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of myelodysplastic syndrome.
Hirai H
Jpn J Clin Oncol; 2003 Apr; 33(4):153-60. PubMed ID: 12810828
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis and targets for therapy in myelodysplastic syndrome (MDS) and MDS-related leukemias.
Karp JE
Curr Opin Oncol; 1998 Jan; 10(1):3-9. PubMed ID: 9466478
[TBL] [Abstract][Full Text] [Related]
4. Understanding the pathogenesis of myelodysplastic syndromes.
Delforge M
Hematol J; 2003; 4(5):303-9. PubMed ID: 14502253
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
Nolte F; Hofmann WK
Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms involved in the progression of myelodysplastic syndrome.
Nolte F; Hofmann WK
Future Oncol; 2010 Mar; 6(3):445-55. PubMed ID: 20222800
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndrome: review of the cytogenetic and molecular data.
Mhawech P; Saleem A
Crit Rev Oncol Hematol; 2001 Dec; 40(3):229-38. PubMed ID: 11738946
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathogenesis of MDS.
Look AT
Hematology Am Soc Hematol Educ Program; 2005; ():156-60. PubMed ID: 16304374
[TBL] [Abstract][Full Text] [Related]
10. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic features of myelodysplastic syndromes (MDS).
Willman CL
Leukemia; 1998 Sep; 12 Suppl 1():S2-6. PubMed ID: 9777886
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic aspects of myelodysplastic syndromes.
Bartram CR
Hematol Oncol Clin North Am; 1992 Jun; 6(3):557-70. PubMed ID: 1613006
[TBL] [Abstract][Full Text] [Related]
13. Genetic lesions in preleukemia.
Carter G; Ridge S; Padua RA
Crit Rev Oncog; 1992; 3(4):339-64. PubMed ID: 1420444
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
Jhanwar SC
Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
[TBL] [Abstract][Full Text] [Related]
15. Mutations of myelodysplastic syndromes (MDS): An update.
Ganguly BB; Kadam NN
Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
[TBL] [Abstract][Full Text] [Related]
17. Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis.
Kunze K; Gamerdinger U; Leßig-Owlanj J; Sorokina M; Brobeil A; Tur MK; Blau W; Burchardt A; Käbisch A; Schliesser G; Kiehl M; Rosenwald A; Rummel M; Grimminger F; Hain T; Chakraborty T; Bräuninger A; Gattenlöhner S
Pathol Res Pract; 2014 Jun; 210(6):369-76. PubMed ID: 24674452
[TBL] [Abstract][Full Text] [Related]
18. What biologic factors predict for transformation to AML?
Bejar R
Best Pract Res Clin Haematol; 2018 Dec; 31(4):341-345. PubMed ID: 30466744
[TBL] [Abstract][Full Text] [Related]
19. The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS.
Nakagawa T; Matozaki S
Leuk Lymphoma; 1995 Apr; 17(3-4):335-9. PubMed ID: 8580805
[TBL] [Abstract][Full Text] [Related]
20. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.
Padua RA; McGlynn A; McGlynn H
Cancer Treat Res; 2001; 108():111-57. PubMed ID: 11702597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
